Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02853838
Other study ID # 2014-84
Secondary ID
Status Completed
Phase N/A
First received July 22, 2016
Last updated October 25, 2016
Start date March 2015
Est. completion date October 2016

Study information

Verified date October 2016
Source Universidad del Desarrollo
Contact n/a
Is FDA regulated No
Health authority Chile: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this research is to determine the effect of prolonged slow expiration techniques, provoked coughing and standard therapy compared to chest wall manual vibration and standard therapy in infants between 0 and 12 months old with confirmed diagnosis of acute bronchiolitis SRV (+). The effect will be measured on respiratory insufficiency and use of supplementary oxygen.


Description:

Bronchiolitis is the main cause of hospital admission for infants under 1 year old in Chile. Currently, approximately 4800 children are admitted to the hospital during the cold season, affecting the health services' effectiveness. The most frequent causal agent is the Respiratory Syncytial Virus (RSV). To date, there is no specific treatment for this disease and only support measures are recommended.

Chest physiotherapy is a support measure that improves the mucociliary clearance and reduces obstruction of the airways.

A clinical trial on the effect of prolonged slow expiration (PSE), chest wall vibrations, and provoked coughing as treatment for bronchiolitis in infants admitted to the hospital found that the subgroup with RSV required oxygen for 10 hours less than the control group. Gomes and Postiaux (2012) reported a 50% decrease on respiratory distress measured by the Wang score when PSE and suction were compared to traditional chest physiotherapy techniques in patients with bronchiolitis RSV(+).

Currently recommendations in Chile suggest chest physiotherapy for outpatients with bronchiolitis, but the guideline does not refer to the case of inpatients. It is proposed to carry out a randomized controlled trial in infants under one year old. The active group will receive standard therapy, PSE, and provoked coughing, while the control group will receive standard therapy and manual chest wall vibrations. The effectiveness of chest physiotherapy will be measured though a clinical score of respiratory distress, hours using supplementary oxygen, vital signs before and after the intervention in both groups during hospital stay. The main outcome is clinical severity score 48 hours after admission.


Recruitment information / eligibility

Status Completed
Enrollment 204
Est. completion date October 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Both
Age group N/A to 12 Months
Eligibility Inclusion Criteria:

- Clinical diagnosis of bronchiolitis.

- RSV positive in direct immunofluorescence assay.

- Wang clinical severity score = 4 points.

Exclusion Criteria:

- Patients with heart or neurological diseases.

- Previous episodes of wheezing.

- Chronic conditions such as bronchopulmonary dysplasia, immunodeficiency, or congenital diseases.

- Need of mechanical ventilation in Intensive Care Unit

- Contraindication criteria for chest physiotherapy (i.e. Pneumothorax, ribs fractures, hemodynamic instability).

- Patients not receiving supplementary oxygen.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Prolonged slow expiration+provoked coughing
Five cycles of prolonged slow expiration and provoked coughing, which will be repeated five times. During the prolonged slow expiration, the infant will be in supine while the therapist applies pressure at the same time on the rib cage and abdomen during spontaneous expiration. The pressure is applied slowly during two o three respiratory cycles, only during the final phase of expiration.
Manual chest wall vibration
Five cycles of manual chest wall vibrations during 20 seconds each, being repeated five times. The manual chest wall vibrations are oscillatory maneuvers applied on the thorax to improve mucociliary clearance of bronchial mucus and ease its removal.
Standard Therapy
Standard therapy (ST): nasopharyngeal suction, oxygen therapy, fluids administration, 0.5% adrenaline nebulization, and chest physiotherapy.

Locations

Country Name City State
Chile Hospital Padre Hurtado Santiago Región Metropolitana

Sponsors (2)

Lead Sponsor Collaborator
Universidad del Desarrollo Hospital Padre Hurtado

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Other Transfer to high complexity unit Categorical variable. Record of number of patients requiring treatment at a higher complexity unit (i.e. ICU) 96 hours No
Primary Clinical score of respiratory distress Wang clinical severity score 48 hours after baseline measurement No
Secondary Hours of supplementary oxygen 48 hours after baseline measurement No
Secondary Peripheral blood oxygen level Oxygen level or saturation is measured with a pulse oximeter Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
Secondary Heart rate Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
Secondary Respiratory rate Wang clinical severity score Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
Secondary wheezing Wang clinical severity score Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
Secondary Rib cage retractions Wang clinical severity score Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
Secondary General clinical condition Wang clinical severity score Baseline, 30 min, 60 min, 120 min,12 hours, 24 hours, 36 hours, and 48 hours. No
See also
  Status Clinical Trial Phase
Recruiting NCT04989114 - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis N/A
Recruiting NCT04287959 - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow) N/A
Not yet recruiting NCT01618175 - Home Oxygen Treatment of Childhood Acute Bronchiolitis N/A
Completed NCT01247064 - Hypertonic Saline for Acute Bronchiolitis Phase 4
Completed NCT03062917 - Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis N/A
Recruiting NCT06030505 - Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
Completed NCT02571517 - Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis Phase 4
Terminated NCT03252119 - High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis N/A
Active, not recruiting NCT04740294 - Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis Phase 2/Phase 3
Terminated NCT03959384 - Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age Phase 3
Completed NCT00119002 - The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis Phase 4
Terminated NCT04221087 - Steroid Use in Non-RSV Bronchiolitis Phase 4
Recruiting NCT04764929 - Pediatric Helmet CPAP Pilot Study N/A
Completed NCT00122785 - Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children N/A